BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1280569)

  • 1. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.
    Hollingshead LM; Faulds D; Fitton A
    Drugs; 1992 Nov; 44(5):835-57. PubMed ID: 1280569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bepridil treatment of chronic stable angina: a review of comparative studies versus placebo, nifedipine, and diltiazem.
    DiBianco R
    Am J Cardiol; 1992 Apr; 69(11):56D-62D. PubMed ID: 1532468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group.
    Singh BN
    Am J Cardiol; 1991 Aug; 68(4):306-12. PubMed ID: 1858672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bepridil and diltiazem on ventricular repolarization in angina pectoris.
    Funck-Brentano C; Coudray P; Planellas J; Motté G; Jaillon P
    Am J Cardiol; 1990 Oct; 66(10):812-7. PubMed ID: 2220578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of bepridil versus placebo in angina pectoris: treatment and withdrawal studies.
    Shapiro W
    Am J Cardiol; 1992 Apr; 69(11):43D-49D. PubMed ID: 1553891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN; Markham A
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bepridil with nadolol for angina pectoris.
    Pflugfelder PW; Humen DP; O'Brien PA; Purves PD; Jablonsky G; Kostuk WJ
    Am J Cardiol; 1987 Jun; 59(15):1283-8. PubMed ID: 3296724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.
    DiBianco R; Alpert J; Katz RJ; Spann J; Chesler E; Ferri DP; Larca LJ; Costello RB; Gore JM; Eisenman MJ
    Am J Cardiol; 1984 Jan; 53(1):35-41. PubMed ID: 6362386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bepridil hydrochloride compared with placebo in patients with stable angina pectoris.
    Narahara KA; Singh BN; Karliner JS; Corday SR; Hossack KF
    Am J Cardiol; 1992 Apr; 69(11):37D-42D. PubMed ID: 1553890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bepridil: a new long-acting calcium channel blocking agent.
    Zeller FP; Spinler SA
    Drug Intell Clin Pharm; 1987 Jun; 21(6):487-92. PubMed ID: 3301244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
    Shapiro W; DiBianco R; Thadani U
    Am J Cardiol; 1985 Mar; 55(7):36C-42C. PubMed ID: 3919556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of bepridil in patients with chronic stable angina pectoris: results of a multicenter, placebo-controlled study of extended bepridil use.
    DiBianco R; Katz RJ; Chesler E; Alpert JS; Spann JF
    Am J Cardiol; 1985 Mar; 55(7):50C-54C. PubMed ID: 3919557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bepridil versus verapamil in stable angina pectoris--a controlled clinical trial.
    Nielsen HK; Krusell LR; Husted SE; Pluymers RJ
    Int J Cardiol; 1989 Jun; 23(3):357-64. PubMed ID: 2500401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.
    Alpert JS; Coumel P; Greeff K; Krikler DM; Remme WJ; Schönbaum E; Verduyn CW
    Pharmatherapeutica; 1985; 4(4):195-222. PubMed ID: 2414784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
    Kumar S; Hall RJ
    Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of amlodipine in myocardial ischaemia.
    Taylor SH
    Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of amlodipine for angina pectoris.
    Taylor SH
    Am J Cardiol; 1994 Jan; 73(3):28A-33A. PubMed ID: 8310973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.